Newsletter | June 12, 2019

06.12.19 -- Could Microbiome-Based Therapies Upend The Asthma And COPD Markets?

Featured Editorial
Could Microbiome-Based Therapies Upend The Asthma And COPD Markets?
By Kristine Mackin, Ph.D., Decision Resources Group (DRG)

Respiratory diseases are an appealing target for future microbiome development, with the combined asthma and chronic obstructive pulmonary disease (COPD) market approaching $30 billion by 2020 in the U.S. alone, and with significant unmet needs remaining in both markets. 

4 Approaches To Data Access Strategy — And How To Apply Them Throughout Drug Development
By Jamie Cartland and Philip Winkworth, PA Consulting

It will be increasingly important for biopharma companies to employ ingenious strategies to access data already existing in the healthcare environment, moving away from solely building and owning data sets. 

Industry Insights
Answering Today’s Pharma Dilemma Of Build Or Buy
Article | By Charles Christy, Lonza Pharma & Biotech

A new business and operating model may address the build or buy dilemma, offering an innovative and agile way to manage demand uncertainty and reduce the risks associated with early investment decisions.

Making Next-Generation Manufacturing Work In Bioprocessing
Article | By Herb Lutz, MilliporeSigma

When it comes to downstream bioprocessing, we already have many of the technologies we require – we only need to focus on adapting them.

Purification Of An Acidic Enzyme Using Ceramic Hydroxyapatite Chromatography
Application Note | By Louisa Vang and Xuemei He, Bio-Rad Laboratories, Inc.

Compare two purification strategies and their effectiveness to offer high product yields and clearance of acidic impurities from the expression host cells.

Selecting A CMO: Top Considerations
Article | AbbVie

Choosing the right contract organization to handle the development and manufacturing of a drug product is of critical importance. Here are tips to ensure a successful outcome.

Direct-To-Representative Sample Distribution Services
Case Study | Thermo Fisher Scientific

Pharma manufacturers use a range of marketing channels to promote their prescription drug product, including sales representatives ‘hand carrying’ samples to healthcare practitioners within their territories.

Sensitive And Reproducible SPR-Based Concentration And Ligand-Binding Analyses
White Paper | GE Healthcare Life Sciences

Surface plasmon resonance (SPR) assays are used across the life cycle of a biopharmaceutical, from target identification through CQA determination, development, and ongoing quality control. This article focuses on concentration assays associated with late-stage development and biotherapeutic drug chemical manufacturing and control.

Outsourced Manufacturing: Comparing Large Vs. Small Molecule
Infographic | ISR Reports

Results from a Q42017 ISR survey of 177 biopharmaceutical sponsors asking how the proportion of outsourced manufacturing for large molecule products compares to that of small molecule products.

Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.